Target intelligence / Profile preview

Olfactory receptor 52N2 (OR52N2)

Target
OR52N2
Molecular classification
G protein-coupled receptor (GPCR), Receptor, 7-transmembrane domain protein, Olfactory receptor (subtype of GPCR)
01

Overview

Olfactory receptor 52N2 is a G protein-coupled receptor located in the olfactory epithelium, where it mediates the detection of specific odorant molecules in the nasal cavity. The protein has a characteristic seven-transmembrane domain structure and is part of the largest gene family in the human genome. Upon binding to its odorant ligand, the receptor triggers a cascade involving G protein activation and cAMP increase, resulting in neuronal signaling to the brain and odor perception. Members of the OR52 subfamily, including OR52N2, are selective for carboxylic acid odorants with long hydrocarbon chains, and bind them via a specific pocket formed within transmembrane domains of the receptor. No drugs are known to act on this receptor, and its primary function is in olfactory signal transduction.

Other names
Olfactory receptor family 52 subfamily N member 2OR52N2
02

Mechanism of action

Binding of odorant molecules (often carboxylic acids with hydrocarbon tails for the OR52 subfamily) to the receptor triggers a conformational change in the receptor, which activates an olfactory-specific G protein (G_olf or G_s). This activation, in turn, stimulates adenylate cyclase, increasing cAMP, which opens cyclic nucleotide-gated ion channels, leading to neuron depolarization and signal transmission to the brain.

03

Biological functions

Signal transductionInitiation of neuronal response to odorantsOdorant recognition
04

Disease associations

None reported in literature; olfactory receptors are primarily involved in sensory perception and have not been directly implicated in major diseases as targets
05

Safety considerations

None known, as OR52N2 is not a drug target, and no therapies are directed at it. Challenges for therapeutic GPCR targeting do not apply to olfactory-specific receptors
06

Interacting drugs

None known; there are currently no approved drugs targeting specific olfactory receptors for therapeutic purposes
07

Biomarkers

None established for clinical use

Beyond the preview

Go deeper on Olfactory receptor 52N2 (OR52N2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Olfactory receptor 52N2 (OR52N2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call